Immuron (IMRN) Change in Receivables (2016 - 2023)

Immuron's (IMRN) quarterly Change in Receivables came in at $2.2 million in Q4 2023, up 281.59% year-on-year from $583772.0 in Q4 2022, and up 281.59% quarter-over-quarter from $583772.0 in Q4 2022.

Immuron (IMRN) Change in Receivables (2016 - 2023) Analysis & Trends

Immuron's Change in Receivables history runs 7 years deep, the most recent figure standing at $2.2 million for Q4 2023.

  • On a quarterly basis, Change in Receivables rose 281.59% year-over-year to $2.2 million in Q4 2023; TTM through Dec 2023 was $2.6 million, a 231.59% increase from a year earlier, with the FY2025 full-year figure at $361172.0, down 42.54% from the prior year.
  • Change in Receivables improved to $2.2 million in Q4 2023 per IMRN's latest filing, from $583772.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.2 million in Q4 2023 and bottomed at -$241381.0 in Q2 2022.
  • The 5-year median for Change in Receivables is $502025.7 (2020), against an average of $614727.0.
  • Across the five-year window, Change in Receivables tumbled 1460.68% in 2022 and soared 281.59% in 2023, its largest moves.
  • Year by year, Change in Receivables stood at $680337.0 in 2019, then plunged by 38.22% to $420279.3 in 2020, then sank by 95.78% to $17739.8 in 2021, then soared by 3190.75% to $583772.0 in 2022, then surged by 281.59% to $2.2 million in 2023.
  • Per Business Quant, the three latest IMRN Change in Receivables figures stand at $2.2 million (Q4 2023), $583772.0 (Q4 2022), and -$241381.0 (Q2 2022).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 75.30 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immuron 255.19 Mn 243.53 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 2.23 Mn
Dec 31, 2023 2.23 Mn
Dec 31, 2022 583,772.00
Dec 31, 2022 583,772.00
Jun 30, 2022 -241,380.99
Jun 30, 2022 -241,380.99
Jun 30, 2021 17,739.76
Jun 30, 2021 17,739.76
Jun 30, 2020 420,279.30
Jun 30, 2020 420,279.30
Dec 31, 2019 680,337.00
Dec 31, 2019 680,337.00
Dec 31, 2017 923,408.71
Dec 31, 2017 923,408.71
Dec 31, 2016 501,319.99
Dec 31, 2016 501,319.99